Individualising HT considering metabolic risk factors and breast cancer.

Abstract

Despite the time and evidence from observational studies, the balance between risk and benefit of using hormone therapy in postmenopausal women without comorbidities remains uncertain. Hormone therapy for menopausal symptoms remains in use mainly to relieve vasomotor symptoms but still leaves questions about its effect in preventing chronic diseases. The… (More)

Topics

  • Presentations referencing similar topics